International Cannabis Weekly: 107

• British MPs claim recreational cannabis could be legal in 5-10 years.
• Epidiolex receives market approval from the European Medicines Agency.
• New York state decriminalises cannabis.

• Swiss CBD prices in free-fall three years post-legalisation.
• The cannabis industry can help boost UK employment.
• Flowr Corporation to begin medical cannabis cultivation in Portugal.
• German pharmacies need more information on medical cannabis.
• Regulation and research needed to professionalise the UK CBD market.
• Pricing and policing are key to Malta’s medical cannabis market.
• Germany is underestimating demand for medical cannabis.
• Coca Cola heir launches cannabis bank and cryptocurrency in Switzerland.

• Uruguay has granted 19 cannabis cultivation licences.
• Aphria receives licence to open its first dispensary in Kingston, Jamaica.
• Saint Kitts and Nevis and Dominica reiterate commitment to decriminalising cannabis.

• Bill enabling 2020 cannabis referendum introduced in New Zealand’s parliament.
• Australian cannabis industry could significantly boost the Northern Territory economy.
• Issues raised in NZ regarding proposed regulation of medical cannabis.

• Thailand will commercialise cannabis if the medical programme succeeds.
• New Delhi High Court dismisses petition to legalise cannabis for medical purposes.
• Thailand’s Minister of Justice warns farmers over cannabis cultivation.
• Indonesia resistant to medical cannabis legislation.

• Cannabis cultivation gets green light in South African province.
• British firm to open CBD extraction facility in Lesotho.
• Medical cannabis legalisation picks up momentum in Kenya.
• Namibian government calls for more science to consider medical cannabis legislation.
• Chinese investor delegation examines South African cannabis industry.

• US Democratic presidential candidates clash over cannabis legislation stance.
• Canadians can now apply for free cannabis possession pardons.
• Israel’s Health Minister to subsidise medical cannabis for autistic children and adults.
• US DEA failing to respond to medical cannabis research applications.
• Alaskan government ends hemp pilot programme due to lack of an existing industry.
• US tennis champion, John Isner, signs deal with CBD company Defy.
• US institute receives US$40 million to study anti-microbial potential in cannabis.

• CBN, another non-psychoactive cannabinoid, offers therapeutic benefits.
• Spanish researchers suggest cannabis causes inflammation of parts of the brain.
• Study suggests that CBD can reduce aggression induced by social isolation.

Europe is set to become the world’s largest legal cannabis market over the next five years. Our industry-leading report examines the opportunities, regulations and emerging trends across 33 European states, in a market worth a potential €123 billion by 2028. Learn more:

Download Your Free Report Now

Prohibition Partners help brands position themselves as thought-leaders. If you’re interested in marketing your brand to the key decision-makers in the international cannabis industry, contact us today to discuss sponsoring our upcoming reports.

Get in Touch